Merkel cell carcinoma

Clinical practice guidelines in oncology™

Stanley J. Miller, Murad Alam, James Andersen, Daniel Berg, Christopher K. Bichakjian, Glen Bowen, Richard T. Cheney, Frank Glass, Roy C. Grekin, James M. Grichnik, Timothy M. Johnson, Margaret Anne Kessinger, Nancy Y. Lee, Stuart Lessin, Daniel Lydiatt, Lawrence W. Margolis, Kishwer S. Nehal, Paul Nghiem, Allan R. Oseroff, E. William Rosenberg & 2 others Ashok R. Shaha, Ronald J. Siegle

Research output: Contribution to journalReview article

16 Citations (Scopus)

Abstract

Merkel cell carcinoma (MCC) is a rare, aggressive cutaneous tumor that combines the local recurrence rates of infiltrative non-melanoma skin cancer with the regional and distant metastatic rates of thick melanoma. The mortality rate of MCC exceeds that of melanoma, and the 5-year disease-specific survival rate is 64%. These guidelines and most biomedical literature suggest that the workup of a patient with MCC should include chest radiograph and additional studies as clinically indicated. These guidelines, which the NCCN Non-Melanoma Skin Cancer Panel developed as a supplement to those for squamous cell and basal cell skin cancer, also outline treatment strategies.

Original languageEnglish (US)
Pages (from-to)704-712
Number of pages9
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume4
Issue number7
StatePublished - Aug 1 2006

Fingerprint

Merkel Cell Carcinoma
Skin Neoplasms
Practice Guidelines
Melanoma
Basal Cell Neoplasms
Guidelines
Thorax
Survival Rate
Epithelial Cells
Recurrence
Skin
Mortality
Neoplasms
Therapeutics

Keywords

  • Merkel cell carcinoma
  • NCCN Clinical Practice Guidelines
  • Neuroendocrine sarcoma
  • Nonmelanoma skin cancer
  • Sentinel lymph node biopsy

ASJC Scopus subject areas

  • Oncology

Cite this

Miller, S. J., Alam, M., Andersen, J., Berg, D., Bichakjian, C. K., Bowen, G., ... Siegle, R. J. (2006). Merkel cell carcinoma: Clinical practice guidelines in oncology™. JNCCN Journal of the National Comprehensive Cancer Network, 4(7), 704-712.

Merkel cell carcinoma : Clinical practice guidelines in oncology™. / Miller, Stanley J.; Alam, Murad; Andersen, James; Berg, Daniel; Bichakjian, Christopher K.; Bowen, Glen; Cheney, Richard T.; Glass, Frank; Grekin, Roy C.; Grichnik, James M.; Johnson, Timothy M.; Kessinger, Margaret Anne; Lee, Nancy Y.; Lessin, Stuart; Lydiatt, Daniel; Margolis, Lawrence W.; Nehal, Kishwer S.; Nghiem, Paul; Oseroff, Allan R.; Rosenberg, E. William; Shaha, Ashok R.; Siegle, Ronald J.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 4, No. 7, 01.08.2006, p. 704-712.

Research output: Contribution to journalReview article

Miller, SJ, Alam, M, Andersen, J, Berg, D, Bichakjian, CK, Bowen, G, Cheney, RT, Glass, F, Grekin, RC, Grichnik, JM, Johnson, TM, Kessinger, MA, Lee, NY, Lessin, S, Lydiatt, D, Margolis, LW, Nehal, KS, Nghiem, P, Oseroff, AR, Rosenberg, EW, Shaha, AR & Siegle, RJ 2006, 'Merkel cell carcinoma: Clinical practice guidelines in oncology™', JNCCN Journal of the National Comprehensive Cancer Network, vol. 4, no. 7, pp. 704-712.
Miller SJ, Alam M, Andersen J, Berg D, Bichakjian CK, Bowen G et al. Merkel cell carcinoma: Clinical practice guidelines in oncology™. JNCCN Journal of the National Comprehensive Cancer Network. 2006 Aug 1;4(7):704-712.
Miller, Stanley J. ; Alam, Murad ; Andersen, James ; Berg, Daniel ; Bichakjian, Christopher K. ; Bowen, Glen ; Cheney, Richard T. ; Glass, Frank ; Grekin, Roy C. ; Grichnik, James M. ; Johnson, Timothy M. ; Kessinger, Margaret Anne ; Lee, Nancy Y. ; Lessin, Stuart ; Lydiatt, Daniel ; Margolis, Lawrence W. ; Nehal, Kishwer S. ; Nghiem, Paul ; Oseroff, Allan R. ; Rosenberg, E. William ; Shaha, Ashok R. ; Siegle, Ronald J. / Merkel cell carcinoma : Clinical practice guidelines in oncology™. In: JNCCN Journal of the National Comprehensive Cancer Network. 2006 ; Vol. 4, No. 7. pp. 704-712.
@article{5ae252bbf7f7481ca0a2015f43c54377,
title = "Merkel cell carcinoma: Clinical practice guidelines in oncology™",
abstract = "Merkel cell carcinoma (MCC) is a rare, aggressive cutaneous tumor that combines the local recurrence rates of infiltrative non-melanoma skin cancer with the regional and distant metastatic rates of thick melanoma. The mortality rate of MCC exceeds that of melanoma, and the 5-year disease-specific survival rate is 64{\%}. These guidelines and most biomedical literature suggest that the workup of a patient with MCC should include chest radiograph and additional studies as clinically indicated. These guidelines, which the NCCN Non-Melanoma Skin Cancer Panel developed as a supplement to those for squamous cell and basal cell skin cancer, also outline treatment strategies.",
keywords = "Merkel cell carcinoma, NCCN Clinical Practice Guidelines, Neuroendocrine sarcoma, Nonmelanoma skin cancer, Sentinel lymph node biopsy",
author = "Miller, {Stanley J.} and Murad Alam and James Andersen and Daniel Berg and Bichakjian, {Christopher K.} and Glen Bowen and Cheney, {Richard T.} and Frank Glass and Grekin, {Roy C.} and Grichnik, {James M.} and Johnson, {Timothy M.} and Kessinger, {Margaret Anne} and Lee, {Nancy Y.} and Stuart Lessin and Daniel Lydiatt and Margolis, {Lawrence W.} and Nehal, {Kishwer S.} and Paul Nghiem and Oseroff, {Allan R.} and Rosenberg, {E. William} and Shaha, {Ashok R.} and Siegle, {Ronald J.}",
year = "2006",
month = "8",
day = "1",
language = "English (US)",
volume = "4",
pages = "704--712",
journal = "JNCCN Journal of the National Comprehensive Cancer Network",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "7",

}

TY - JOUR

T1 - Merkel cell carcinoma

T2 - Clinical practice guidelines in oncology™

AU - Miller, Stanley J.

AU - Alam, Murad

AU - Andersen, James

AU - Berg, Daniel

AU - Bichakjian, Christopher K.

AU - Bowen, Glen

AU - Cheney, Richard T.

AU - Glass, Frank

AU - Grekin, Roy C.

AU - Grichnik, James M.

AU - Johnson, Timothy M.

AU - Kessinger, Margaret Anne

AU - Lee, Nancy Y.

AU - Lessin, Stuart

AU - Lydiatt, Daniel

AU - Margolis, Lawrence W.

AU - Nehal, Kishwer S.

AU - Nghiem, Paul

AU - Oseroff, Allan R.

AU - Rosenberg, E. William

AU - Shaha, Ashok R.

AU - Siegle, Ronald J.

PY - 2006/8/1

Y1 - 2006/8/1

N2 - Merkel cell carcinoma (MCC) is a rare, aggressive cutaneous tumor that combines the local recurrence rates of infiltrative non-melanoma skin cancer with the regional and distant metastatic rates of thick melanoma. The mortality rate of MCC exceeds that of melanoma, and the 5-year disease-specific survival rate is 64%. These guidelines and most biomedical literature suggest that the workup of a patient with MCC should include chest radiograph and additional studies as clinically indicated. These guidelines, which the NCCN Non-Melanoma Skin Cancer Panel developed as a supplement to those for squamous cell and basal cell skin cancer, also outline treatment strategies.

AB - Merkel cell carcinoma (MCC) is a rare, aggressive cutaneous tumor that combines the local recurrence rates of infiltrative non-melanoma skin cancer with the regional and distant metastatic rates of thick melanoma. The mortality rate of MCC exceeds that of melanoma, and the 5-year disease-specific survival rate is 64%. These guidelines and most biomedical literature suggest that the workup of a patient with MCC should include chest radiograph and additional studies as clinically indicated. These guidelines, which the NCCN Non-Melanoma Skin Cancer Panel developed as a supplement to those for squamous cell and basal cell skin cancer, also outline treatment strategies.

KW - Merkel cell carcinoma

KW - NCCN Clinical Practice Guidelines

KW - Neuroendocrine sarcoma

KW - Nonmelanoma skin cancer

KW - Sentinel lymph node biopsy

UR - http://www.scopus.com/inward/record.url?scp=33747697824&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33747697824&partnerID=8YFLogxK

M3 - Review article

VL - 4

SP - 704

EP - 712

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

SN - 1540-1405

IS - 7

ER -